These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25562927)

  • 21. Tetrabenazine.
    Fasano A; Bentivoglio AR
    Expert Opin Pharmacother; 2009 Dec; 10(17):2883-96. PubMed ID: 19929707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study.
    Dorsey ER; Brocht AF; Nichols PE; Darwin KC; Anderson KE; Beck CA; Singh S; Biglan KM; Shoulson I
    J Huntingtons Dis; 2013; 2(4):509-15. PubMed ID: 25062735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome.
    Paton DM
    Drugs Today (Barc); 2017 Feb; 53(2):89-102. PubMed ID: 28387387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of tetrabenazine for Huntington's disease-associated chorea.
    Poon LH; Kang GA; Lee AJ
    Ann Pharmacother; 2010 Jun; 44(6):1080-9. PubMed ID: 20442355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrabenazine Treatment Patterns and Outcomes for Chorea Associated with Huntington Disease: A Retrospective Chart Review.
    Claassen DO; Iyer RG; Shah-Manek B; DiBonaventura M; Abler V; Sung VW
    J Huntingtons Dis; 2018; 7(4):345-353. PubMed ID: 30282372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrabenazine (Xenazine) for Huntington's chorea.
    Med Lett Drugs Ther; 2009 Jan; 51(1304):7-8. PubMed ID: 19172140
    [No Abstract]   [Full Text] [Related]  

  • 27. Stuck in the middle: Huntington's disease or not Huntington's disease?
    Ziso B; Larner AJ; Alusi SH
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e85-6. PubMed ID: 25716512
    [No Abstract]   [Full Text] [Related]  

  • 28. The suppression of involuntary movements with tetrabenazine.
    McLellan DL
    Scott Med J; 1972 Nov; 17(11):367-70. PubMed ID: 4264428
    [No Abstract]   [Full Text] [Related]  

  • 29. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
    Dean M; Sung VW
    Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome induced by combination therapy with tetrabenazine and tiapride in a Japanese patient with Huntington's disease at the terminal stage of recurrent breast cancer.
    Nozaki I; Furukawa Y; Kato-Motozaki Y; Ikeda T; Tagami A; Takahashi K; Ishida C; Komai K
    Intern Med; 2014; 53(11):1201-4. PubMed ID: 24881749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetrabenazine as a cause of neuroleptic malignant syndrome.
    Ossemann M; Sindic CJ; Laterre C
    Mov Disord; 1996 Jan; 11(1):95. PubMed ID: 8771075
    [No Abstract]   [Full Text] [Related]  

  • 32. Tetrabenazine in the treatment of Huntington's chorea.
    Huang CY; McLeod JG; Holland RT; Elliot C
    Med J Aust; 1976 Apr; 1(16):583-4. PubMed ID: 132600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea.
    McLellan DL; Chalmers RJ; Johnson RH
    Lancet; 1974 Jan; 1(7848):104-7. PubMed ID: 4130307
    [No Abstract]   [Full Text] [Related]  

  • 34. New drugs: Clevidipine butyrate, difluprednate, and tetrabenazine.
    Hussar DA
    J Am Pharm Assoc (2003); 2008; 48(6):815-7, 819, 821. PubMed ID: 19019814
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: Tetrabenazine in chorea.
    Astin KJ; Gumpert EW
    Lancet; 1974 Mar; 1(7856):512. PubMed ID: 4131918
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined therapy with tetrabenazine and pimozide in Huntington's chorea: pilot study.
    McArthur AW; Pollock M; Smidt NA
    N Z Med J; 1976 Feb; 83(558):114-6. PubMed ID: 131917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetrabenazine for Huntington's chorea.
    Soutar CA
    Br Med J; 1970 Oct; 4(5726):55. PubMed ID: 4248502
    [No Abstract]   [Full Text] [Related]  

  • 38. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.
    Frank S
    BMC Neurol; 2009 Dec; 9():62. PubMed ID: 20021666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease.
    Kegelmeyer DA; Kloos AD; Fritz NE; Fiumedora MM; White SE; Kostyk SK
    J Neurol Sci; 2014 Dec; 347(1-2):219-23. PubMed ID: 25456459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tetrabenazine use on restless legs syndrome.
    Ondo WG; Jia JJ
    Sleep Med; 2010 Oct; 11(9):958-9. PubMed ID: 20817597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.